MPM BioVentures 2014 L.P. 13D and 13G filings for Werewolf Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-03 7:04 pm Sale | 2025-12-01 | 13D | Werewolf Therapeutics, Inc. HOWL | MPM BioVentures 2014 L.P. | 4,867,341 10.000% | -614,198 (-11.20%) | Filing |
| 2025-11-17 8:00 pm Sale | 2025-11-13 | 13D | Werewolf Therapeutics, Inc. HOWL | MPM BioVentures 2014 L.P. | 5,481,539 11.300% | -666,071 (-10.83%) | Filing |
| 2025-11-04 6:33 pm Purchase | 2025-10-31 | 13D | Werewolf Therapeutics, Inc. HOWL | MPM BioVentures 2014 L.P. | 6,147,610 13.400% | 6,147,610 (New Position) | Filing |